N. Gils

The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

L. Heitman, A. Lichtman, K. Erdélyi, 2016, British journal of pharmacology.